Adalimumab

Details

Files
Generic Name:
Adalimumab
Project Status:
Complete
Therapeutic Area:
Arthritis, Psoriatic
Manufacturer:
Abbott Laboratories Limited
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0066-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Resubmission
Indications:
Arthritis, Psoriatic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: